• Jean-Christophe Orban, Catherine Garrel, Didier Déroche, Florian Cattet, Patricia Ferrari, Frédéric Berthier, and Carole Ichai.
• Intensive Care Unit, Pasteur Hospital, Nice University Hospital, Nice, France. Electronic address: orban.jc@chu-nice.fr.
• Am J Emerg Med. 2016 Aug 1; 34 (8): 1561-6.

IntroductionPathophysiology of cardiac arrest corresponds to a whole body ischemia-reperfusion. This phenomenon is usually associated with an oxidative stress in various settings, but few data are available on cardiac arrest in human. The aim of the present study was to evaluate different oxidative stress markers in out-of-hospital cardiac arrest (OHCA) patients treated with therapeutic hypothermia.Materials And MethodsWe conducted a prospective study assessing oxidative stress markers (thiobarbituric acid reactive species, carbonyls, thiols, glutathione, and glutathione peroxidase) in OHCA patients treated with therapeutic hypothermia. Measurements were performed during the 4 days after admission and compared between good and poor outcome patients according to Cerebral Performance Category.ResultsThirty-four patients were included, 10 good and 24 poor outcomes at 6 months. Thiobarbituric acid reactive species were higher in the poor outcome group on admission and when therapeutic hypothermia was reached. The other markers were not different between groups. No markers seemed modified by the use of therapeutic hypothermia in each group.ConclusionsAfter OHCA, good outcome patients exhibit lower oxidative stress markers than poor outcome patients. Thiobarbituric acid reactive species appears to be an early prognostic parameter. Oxidative stress markers seem not mitigated by therapeutic hypothermia.Copyright © 2016 Elsevier Inc. All rights reserved.

28 keywords...

hide…